0001209191-11-039504.txt : 20110714
0001209191-11-039504.hdr.sgml : 20110714
20110714150238
ACCESSION NUMBER: 0001209191-11-039504
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20110713
FILED AS OF DATE: 20110714
DATE AS OF CHANGE: 20110714
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 130 WAVERLY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139-4242
BUSINESS PHONE: 6165776000
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Emmens Matthew
CENTRAL INDEX KEY: 0001298332
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 11967872
MAIL ADDRESS:
STREET 1: C/O VERTEX PHARMACEUTICALS INCORPORATED
STREET 2: 130 WAVERLY ST., ATTN: GENERAL COUNSEL
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
doc4.xml
FORM 4 SUBMISSION
X0303
4
2011-07-13
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001298332
Emmens Matthew
C/O VERTEX PHARMACEUTICALS INCORPORATED
130 WAVERLY ST
CAMBRIDGE
MA
02139
1
1
0
0
CEO & President
Stock Option
51.75
2011-07-13
4
A
0
118000
0.00
A
2011-10-13
2021-07-12
Common Stock
118000
118000
D
Right to buy under 2006 Stock and Option Plan, vesting in 16 quarterly installments from 07/13/2011.
Valerie L. Andrews, Attorney-In-Fact
2011-07-14